Category: Pharmaceuticals Company Reports
Pharmaceuticals Company Reports market research reports by Plunkett Research, Ltd.
-
Adamis Pharmaceuticals Corporation (ADMP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Adamis Pharmaceuticals Corporation (ADMP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Adamis Pharmaceuticals Corporation (ADMP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within ... Read More
-
West Pharmaceutical Services Inc (WST:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
West Pharmaceutical Services Inc (WST:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry West Pharmaceutical Services Inc (WST:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its I ... Read More
-
RVL Pharmaceuticals PLC (RVLP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
RVL Pharmaceuticals PLC (RVLP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry RVL Pharmaceuticals PLC (RVLP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Fin ... Read More
-
Curis Inc (CRIS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Curis Inc (CRIS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Curis Inc (CRIS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new repor ... Read More
-
Lexicon Pharmaceuticals Inc (LXRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Lexicon Pharmaceuticals Inc (LXRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Lexicon Pharmaceuticals Inc (LXRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. ... Read More
-
Bellicum Pharmaceuticals Inc (BLCM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Bellicum Pharmaceuticals Inc (BLCM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Bellicum Pharmaceuticals Inc (BLCM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industr ... Read More
-
NGM Biopharmaceuticals Inc (NGM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
NGM Biopharmaceuticals Inc (NGM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry NGM Biopharmaceuticals Inc (NGM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key ... Read More
-
Ultragenyx Pharmaceutical Inc (RARE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Ultragenyx Pharmaceutical Inc (RARE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Ultragenyx Pharmaceutical Inc (RARE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Indus ... Read More
-
Vanda Pharmaceuticals Inc (VNDA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Vanda Pharmaceuticals Inc (VNDA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Vanda Pharmaceuticals Inc (VNDA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key ... Read More
-
Pfizer Inc (PFE:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Pfizer Inc (PFE:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Pfizer Inc (PFE:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new repor ... Read More
-
Aclaris Therapeutics Inc (ACRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Aclaris Therapeutics Inc (ACRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Aclaris Therapeutics Inc (ACRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key F ... Read More
-
Halozyme Therapeutics Inc (HALO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Halozyme Therapeutics Inc (HALO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Halozyme Therapeutics Inc (HALO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key ... Read More
-
Bristol-Myers Squibb Company (BMY:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Bristol-Myers Squibb Company (BMY:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Bristol-Myers Squibb Company (BMY:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. ... Read More
-
AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industr ... Read More
-
McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings: T ... Read More
-
Merck & Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Merck & Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Merck & Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings: This unique n ... Read More
-
Johnson & Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Johnson & Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Johnson & Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings: This un ... Read More
-
Tarsus Pharmaceuticals Inc (TARS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Tarsus Pharmaceuticals Inc (TARS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Tarsus Pharmaceuticals Inc (TARS:NAS) compared to its top competitors and compar ... Read More
-
Timber Pharmaceuticals Inc (TMBR:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Timber Pharmaceuticals Inc (TMBR:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Timber Pharmaceuticals Inc (TMBR:ASE) compared to its top competitors and compar ... Read More
-
Acer Therapeutics Inc (ACER:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Acer Therapeutics Inc (ACER:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Acer Therapeutics Inc (ACER:NAS) compared to its top competitors and compared to the ... Read More
-
Navidea Biopharmaceuticals Inc (NAVB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Navidea Biopharmaceuticals Inc (NAVB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Navidea Biopharmaceuticals Inc (NAVB:ASE) compared to its top competitors an ... Read More
-
Syndax Pharmaceuticals (SNDX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Syndax Pharmaceuticals (SNDX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Syndax Pharmaceuticals (SNDX:NAS) compared to its top competitors and compared to th ... Read More
-
Apellis Pharmaceuticals (APLS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Apellis Pharmaceuticals (APLS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Apellis Pharmaceuticals (APLS:NAS) compared to its top competitors and compared to ... Read More
-
Rhythm Pharmaceuticals (RYTM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Rhythm Pharmaceuticals (RYTM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Rhythm Pharmaceuticals (RYTM:NAS) compared to its top competitors and compared to th ... Read More
-
Actinium Pharmaceuticals Inc (ATNM:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Actinium Pharmaceuticals Inc (ATNM:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Actinium Pharmaceuticals Inc (ATNM:ASE) compared to its top competitors and co ... Read More
Research Assistance
